AHA​ 2025 7 - 10 November 2025

Comparing cardiovascular outcomes in new users of oral semaglutide versus other noninsulin glucose-lowering therapies

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Diabetes
Congress poster
GLP-1 RA
Semaglutide (oral)
RWE HEOR